Parrish Capital
AZN icon

Parrish Capital’s AstraZeneca AZN Stock Holding History

Parrish Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.58M Buy
9,792
+105
+1% +$17.5K 1.54% 19
2026
Q2 		$1.84M Sell
9,687
-1,868
-16% -$351K 1.77% 13
2026
Q1 		$2.28M Sell
11,555
-1,278
-10% -$246K 2.03% 8
2025
Q4 		$2.36M Buy
+12,833
New +$2.25M 2.14% 7

Other funds holding AZN

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
ASR Vermogensbeheer
ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return
Generali Asset Management
Generali Asset Management Trieste, Italy $5.73B AUM 29.6% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Parrish Capital's AZN Position: Q3 2026 in Review

Parrish Capital increased its AstraZeneca (AZN) stake by 1.1% in Q3 2026, buying an estimated $17.5K and bringing the position to 9,792 shares worth $1.58M. The position accounts for 1.54% of the portfolio, ranked #19.

Parrish Capital first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.36M in Q4 2025. 556 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Parrish Capital held 9,792 shares of AstraZeneca worth $1.58M as of Q3 2026.
  • Parrish Capital bought 105 AstraZeneca shares in Q3 2026, an estimated $17.5K.
  • AstraZeneca made up 1.54% of Parrish Capital's portfolio in Q3 2026, its #19 holding.
  • Parrish Capital first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • Parrish Capital's AstraZeneca position peaked at $2.36M in Q4 2025.
  • 556 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Parrish Capital's 13F filing for Q3 2026, filed 1 Oct 2026.